These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23641444)

  • 1. The long and winding road Toward Alzheimer prevention FDA offers new guidance on developing drugs for early-stage AD; seeks input.
    Ott BR
    R I Med J (2013); 2013 Apr; 96(4):14-5. PubMed ID: 23641444
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA AD Drug Development Guidance.
    J Nucl Med; 2013 Apr; 54(4):16N. PubMed ID: 23546928
    [No Abstract]   [Full Text] [Related]  

  • 3. Into the darkness of the mind.
    Underwood A
    Newsweek; 2003 Dec; 142(23):90, 92. PubMed ID: 14712575
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA approves memantine drug for treating AD.
    Am J Alzheimers Dis Other Demen; 2003; 18(6):329-30. PubMed ID: 14682078
    [No Abstract]   [Full Text] [Related]  

  • 5. Advancing Alzheimer's disease drug review as a national priority.
    Perry DP
    Alzheimers Dement; 2009 Mar; 5(2):180-1. PubMed ID: 19328455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
    Doody RS
    Alzheimers Dement; 2009 Mar; 5(2):133-6. PubMed ID: 19328443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA user fee may speed approval of Alzheimer's, Parkinson's drugs.
    Geriatrics; 1992 Dec; 47(12):15-6. PubMed ID: 1446840
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA notifications. FDA draft guidance is about new drug development.
    AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18411484
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA seeks input on food labeling changes.
    FDA Drug Bull; 1978; 8(5):31. PubMed ID: 700288
    [No Abstract]   [Full Text] [Related]  

  • 10. Repackaging FDA-approved drugs for degenerative diseases: promises and challenges.
    Cummings JL; Zhong K
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):161-5. PubMed ID: 24502586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA and surrogate endpoints in Alzheimer's disease.
    Osborne R
    Nat Biotechnol; 2008 Aug; 26(8):843. PubMed ID: 18688217
    [No Abstract]   [Full Text] [Related]  

  • 12. Draft guidance for industry on developing medical imaging drugs and biologics; availability--FDA. Availability of guidance.
    Fed Regist; 1998 Oct; 63(198):55067-9. PubMed ID: 10185833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we forget about Alzheimer's?
    Nash JM
    Time; 1999 Nov; 154(19):76. PubMed ID: 10661923
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA approves groundbreaking Alzheimer's drug.
    Provider; 2004 Feb; 30(2):24, 27. PubMed ID: 14964917
    [No Abstract]   [Full Text] [Related]  

  • 15. Food and drug administration guidance sections. A new paradigm for medical devices. Committee for Clinical Review. FDA.
    Watson JT
    ASAIO J; 1994; 40(2):138-44. PubMed ID: 8003750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotechnology: the long and winding road.
    Schaefer E
    Nature; 1990 Aug; 346(6284):501. PubMed ID: 2377217
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention therapeutics of dementia.
    Schneider LS
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S122-30. PubMed ID: 18631988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long and winding road to FDA approval of a novel prostate cancer test: our story.
    Rittenhouse H; Blase A; Shamel B; Schalken J; Groskopf J
    Clin Chem; 2013 Jan; 59(1):32-4. PubMed ID: 23193060
    [No Abstract]   [Full Text] [Related]  

  • 19. The long, winding road of RU-486.
    Check E
    Newsweek; 2000 Oct; 136(14):50. PubMed ID: 11183341
    [No Abstract]   [Full Text] [Related]  

  • 20. Can we do better in developing new drugs for Alzheimer's disease?
    Gauthier S; Scheltens P
    Alzheimers Dement; 2009 Nov; 5(6):489-91. PubMed ID: 19896588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.